Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

PLX4720

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Daiichi Sankyo

Drug class:

BRAF inhibitor

Related drugs:

miR-340 expression	Thyroid Gland Carcinoma	miR-340 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-361 expression	Thyroid Gland Carcinoma	miR-361 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-363 expression	Thyroid Gland Carcinoma	miR-363 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-3651 expression	Thyroid Gland Carcinoma	miR-3651 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-3917 expression	Thyroid Gland Carcinoma	miR-3917 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-409 expression	Thyroid Gland Carcinoma	miR-409 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-4467 expression	Thyroid Gland Carcinoma	miR-4467 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-4473 expression	Thyroid Gland Carcinoma	miR-4473 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-449c expression	Thyroid Gland Carcinoma	miR-449c expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-425 expression	Thyroid Gland Carcinoma	miR-425 expression	Thyroid Gland Carcinoma	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D	PLX4720 Resistant: D – Preclinical PLX4720 Resistant : D
miR-4664 expression	Thyroid Gland Carcinoma	miR-4664 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D
miR-4745 expression	Thyroid Gland Carcinoma	miR-4745 expression	Thyroid Gland Carcinoma	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D	PLX4720 Sensitive: D – Preclinical PLX4720 Sensitive : D